Close

content

Aralez Completes Acquisition Of Toprol-XL  And Its Authorized Generic From AstraZeneca

Aralez Pharmaceuticals Inc a global specialty pharmaceutical company announced that its subsidiary, Aralez Pharmaceuticals Trading DAC (Aralez Ireland), has completed its acquisition of the...

FPS Food and Pharma Systems Announces Production Plant Expansions

FPS Food and Pharma Systems has announced it is expanding its production plant in Fiorenzuola d'Arda for greater flexibility and timeliness on production systems....

Antihypertensive drug Micatrio combination tablets launch in Japan

Nippon Boehringer Ingelheim Co., Ltd. and Astellas Pharma Inc. announced that the companies have newly launched “Micatrio®Combination Tablets,” a combination drug of “Micardis® Tablets”...

AbbVie and Eisai Subsidiary EA Pharma Commence Co-promotion of Fully Human Anti-TNF-a Monoclonal Antibody HUMIRA® in the Field of Gastrointestinal Disease

AbbVie GK announced that EA Pharma and AbbVie will commence the co-promotion of fully human anti-TNF-α monoclonal antibody HUMIRA® for indications in the field...

Biogen Releases TECFIDERA data confirm strong, sustained efficacy in newly diagnosed MS Patients

World pharma today/Drug Research/-Biogen unveiled new TECFIDERA® (dimethyl fumarate) research that reinforces its strong and sustained efficacy in newly diagnosed relapsing-remitting multiple sclerosis (RRMS)...

Chugai and Two Cells Co Ltd Announce a Licensing agreement for “gMSC®1,” a Regenerative Cellular Medicine for Chondrogenesis in the Knee

Chugai Pharma and TWO CELLS Co Ltd announced that on April 25, 2016, both companies concluded a licensing agreement regarding gMSC®1, a regenerative cellular...

Nplate Study In The Lancet Shows Significant Increase In Durable Platelet Response Among Children With Immune Thrombocytopenia

Amgen announced that The Lancet published results from a Phase 3 randomized, double-blind, placebo-controlled study of Nplate in children with symptomatic immune thrombocytopenia. ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read